Here we report the first study investigating CHEK2 1100delC-related tumorigenesis by comparing gene-expression profiles and genomic changes in breast tumors of CHEK2 1100delC-mutation carriers to those of patients negative for any known germline mutations. Here, CHEK2 is linked to breast neoplasm.